Medsurg was Solventum’s largest segment in fiscal 2025, bringing in $4.82B of $8.33B (58%).
| Segment | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Medsurg | $4.59B | $4.63B | $4.64B | $4.82B |
| Dental Solutions | $1.33B | $1.33B | $1.30B | $1.35B |
| Health Information Systems | $1.23B | $1.29B | $1.31B | $1.36B |
| Purification & Filtration | $991.00M | $689.00M | $709.00M | $497.00M |
| All Other | — | $262.00M | $306.00M | $302.00M |
| Total | $8.13B | $8.20B | $8.25B | $8.33B |
Solventum brought in $8.33B from its five segments in fiscal 2025, the year ended December 31, 2025. That was up 0.9% from $8.25B in fiscal 2024. Medsurg was the largest at $4.82B (57.9%), ahead of Health Information Systems at $1.36B (16.3%) and Dental Solutions at $1.35B (16.2%). The other two segments brought in $799.00M combined.
Compared with fiscal 2024, Dental Solutions grew fastest, up 4.2% to $1.35B, while Purification & Filtration fell the most, down 29.9% to $497.00M.
Solventum began breaking out All Other in fiscal 2023, when it brought in $262.00M.
United States was Solventum’s largest region in fiscal 2025, bringing in $4.67B of $8.33B (56%).
| Geography | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| United States | $4.45B | $4.47B | $4.56B | $4.67B |
| International | $3.68B | $3.73B | $3.70B | $3.66B |
| Total | $8.13B | $8.20B | $8.25B | $8.33B |
Solventum brought in $8.33B from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 0.9% from $8.25B in fiscal 2024. United States was the largest at $4.67B (56.1%), ahead of International at $3.66B (43.9%).
Compared with fiscal 2024, United States grew 2.4% to $4.67B, while International fell 1.0% to $3.66B. From fiscal 2022 to 2025, combined revenue from these regions grew from $8.13B to $8.33B, a compound annual growth rate of 0.8%. United States' share of the total rose from 54.7% to 56.1%.
Cost Of Product was Solventum’s largest product and service line in fiscal 2025, bringing in $6.35B of $8.33B (76%).
| Product and Service | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Cost Of Product | $6.30B | $6.30B | $6.35B | $6.35B |
| Cost Of Software & Rentals | $1.83B | $1.90B | $1.91B | $1.98B |
| Total | $8.13B | $8.20B | $8.25B | $8.33B |
Solventum brought in $8.33B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 0.9% from $8.25B in fiscal 2024. Cost Of Product was the largest at $6.35B (76.3%), ahead of Cost Of Software & Rentals at $1.98B (23.7%).
Compared with fiscal 2024, Cost Of Software & Rentals grew 3.7% to $1.98B and Cost Of Product grew 0.0% to $6.35B. From fiscal 2022 to 2025, combined revenue from these lines grew from $8.13B to $8.33B, a compound annual growth rate of 0.8%. Cost Of Product's share of the total fell from 77.5% to 76.3%.
Solventum (SOLV) reports its revenue by segment, by geography and by product and service. In fiscal 2025, Medsurg was its largest segment, bringing in $4.82B (57.9% of the total), followed by Health Information Systems at $1.36B (16.3%).
Medsurg was Solventum's largest segment in fiscal 2025, bringing in $4.82B, or 57.9% of the $8.33B total across its five segments.
United States was Solventum's largest region in fiscal 2025, bringing in $4.67B, or 56.1% of the $8.33B total across its two regions.
Cost Of Product was Solventum's largest product and service line in fiscal 2025, bringing in $6.35B, or 76.3% of the $8.33B total across its two product and service lines.
Among Solventum's segments that make up at least 2% of revenue, Dental Solutions grew fastest in fiscal 2025, up 4.2% from $1.30B to $1.35B.
Every figure comes from Solventum's annual financial filings, as reported. Each line keeps the name Solventum gives it, and years follow its fiscal calendar.
Solventum's revenue by segment goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.